DKCM
ABBV icon

Davidson Kempner Capital Management’s AbbVie ABBV Stock Holding History

Davidson Kempner Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-176,325
Closed -$19.9M – 502
2021
Q2 		$19.9M Sell
176,325
-474,537
-73% -$53.4M 0.15% 95
2021
Q1 		$70.4M Buy
650,862
+211,557
+48% +$22.6M 0.7% 32
2020
Q4 		$47.1M Sell
439,305
-1,297,902
-75% -$125M 0.55% 44
2020
Q3 		$152M Buy
1,737,207
+1,207,007
+228% +$114M 2.16% 9
2020
Q2 		$52.1M Buy
530,200
+200,600
+61% +$17.7M 1.26% 13
2020
Q1 		$25.1M Buy
+329,600
New +$28.1M 0.67% 29

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Davidson Kempner Capital Management's ABBV Position: Q3 2021 in Review

Davidson Kempner Capital Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 176,325 shares — an estimated $19.9M sold.

Davidson Kempner Capital Management first reported a position in ABBV in Q1 2020 and held it in 6 quarters. The position peaked at $152M in Q3 2020. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Davidson Kempner Capital Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 176,325 AbbVie shares in Q3 2021, an estimated $19.9M.
  • Davidson Kempner Capital Management first reported a position in AbbVie in Q1 2020 and held it in 6 quarters.
  • Davidson Kempner Capital Management's AbbVie position peaked at $152M in Q3 2020.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.